¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Christmas disease, factor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • Crohn¡¯s disease
    Å©·Ðº´
  • Crouzon¡¯s disease
    Å©·çÁ¾º´
  • Cushing¡¯s disease
    Äí½Ìº´
  • cystic kidney disease
    ³¶¼ºÄáÆÏº´, ³¶¼º½ÅÀ庴
  • cystine disease
    ½Ã½ºÆ¾º´
  • cystine storage disease
    ½Ã½ºÆ¾ÃàÀûº´
  • cytomegalic inclusion disease
    °Å´ë¼¼Æ÷Æ÷ÇÔº´, °Å´ë¼¼Æ÷ºÀÀÔüº´
  • cardiovascular disease
    ½É(Àå)Ç÷°üÁúȯ
  • Caroli disease
    Ä«·Ñ¸®º´
  • cat-scratch disease
    °í¾çÀÌÇÒÅ¡º´
  • celiac disease
    º¹°­º´, º¹°­Áúȯ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
  • central core disease
    Áß½ÉÇÙº´, Áß½ÉÄھ
  • caloric disease
    °í¿Âº´
  • cerebrovascular disease
    ³úÇ÷°üÁúȯ, ³úÇ÷°üº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÆ÷ÇÔº´
  • disease control
    Áúº´°ü¸®
  • venereal disease control
    ¼ºº´°ü¸®
  • disease
    º´
  • deficiency disease
    ¿µ¾ç°áÇ̺´
  • degenerative disease
    ÅðÇິ
  • degenerative joint disease
    (¢¡osteoarthritis) »À°üÀý¿°, °ñ°üÀý¿°
  • demyelinating disease
    ¸»ÀÌÁýÅ»¶ôº´
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • depression spectrum disease
    ¿ì¿ï½ºÆåÆ®·³º´
  • detergent worker¡¯s disease
    ¼¼Á¤Á¦Ãë±ÞÀÚº´
  • developmental disease
    ¹ß´ÞÀå¾Ö
  • diarrheal disease
    ¼³»çº´
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
  • diffuse interstitial pulmonary disease
    ±¤¹üÀ§»çÀÌÁúÆóº´, ¹Ì¸¸°£ÁúÆóº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • Devics disease=>optic neuromyelitis
    µ¥ºòº´
  • Di Guglielmos disease
    µð±¸±Û¸®¿¤¸ðº´, ÀûÇ÷º´¼º °ñ¼öÁõ.
  • Dorfman-Chanarin syndrome = neutral lipid storage disease
    Áß¼ºÁö¹æÃàÀûÁõ
  • Dowling-Degos disease = reticular pigmented anomaly of the flexures
    ±¼ÃøºÎ ¸Á»ó»ö¼ÒÀÌ»ó(Áõ)
  • Duhrings disease => dermatitis herpetiformis
    Æ÷Áø»ó ÇǺο°
  • Duncans disease .
    ´øÄ­¾¾º´
  • Eagles disease
    À̱۽ºº´
  • Eales disease
    ÀϽºº´
  • Ebola disease
    ¿¡º¼¶óº´
  • Ebola disease
    ¿¡º¼¶ó º´
  • Fabrys disease
    ÆÄºê¸®º´
  • Fabrys disease
    ÆÄºê¸®º´.
  • Fabrys disease
    ÆÄºê¸®º´
  • Farber s disease
    ÆÄ¾Æ¹öº´.
  • Fordyce s disease
    Æ÷¿À´ÙÀ̽ºº´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • hepatocyte growth factor
    °£¼¼Æ÷¼ºÀåÀÎÀÚ
  • histamine sensitizing factor =HSF
    È÷½ºÅ¸¹Î°¨ÀÛÀÎÀÚ(¡­ÊïíÂì×í­).
  • homologous restriction factor
    µ¿Á¾Á¦ÇÑÀÎÀÚ
  • host factor
    ¼÷ÁÖÀÎÀÚ
  • host integration factor (HIF)
    ¼÷ÁÖÅëÇÕÀÎÀÚ
  • hunter blood factor
    ÇåÅÍÇ÷¾×ÀÎÀÚ(?Ì´Ëâ ËöËö).
  • hunter blood factor
    ÇåÅÍÇ÷¾×ÀÎÀÚ(¡­úìäû ì×í­).
  • hyperglycemic glycogenolytic factor
    °íÇ÷´ç¼º ´ç¿øºÐÇØ(¼º) ÀÎÀÚ.
  • hypothalamic releasing factor
    ½Ã»óÇϺιæÃâÀÎÀÚ.
  • hypothalamic releasing factor
    ½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ(ë¤×ãì×í­).
  • hypothalamus releasing factor
    ½Ã»óÇϺÎÀ¯¸®ÀÎÀÚ.
  • inhibition(-tory) factor, macrophage migration
    ´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • intensity factor
    °­µµÀÎÀÚ
  • intrinsic factor
    ³»ÀμºÀÎÀÚ, ³»Àμº¿ä¼Ò, °íÀ¯ÀÎÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • separation factor
    ºÐ¸®ÀÎÀÚ(ÝÂ×îì×í­)
  • serum prothrombin converting factor
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÀÎÀÚ(ï®üµì×í­)
  • serum sulfation factor
    Ç÷û À¯È²È­ÀÎÀÚ(úìôè×¼üÜûùì×í­)
  • serum thymic factor
    Ç÷û °©»ó¼±ÀÎÀÚ(úìôèË£ßÒàÍì×í­)
  • sex factor
    ¼ºÀÎÀÚ(àõì×í­)
  • shape factor
    ¸ð¾çÀÎÀÚ(Ù¼åÆì×í­)
  • sigma factor
    ½Ã±×¸¶ÀÎÀÚ(ì×í­)
  • SLR factor
    SLRÀÎÀÚ(ì×í­)
  • somatotropin factor
    ¼Ò¸¶Å䯮·ÎÇÉ ÀÎÀÚ(ì×í­)
  • specificity factor
    ƯÀ̼º ÀÎÀÚ(÷åì¶àõì×í­)
  • spreading factor
    ÆÛÁü ÀÎÀÚ(ì×í­)
  • stable factor
    ¾ÈÁ¤ÀÎÀÚ(äÌïÒì×í­)
  • steric factor
    ÀÔü ÀÎÀÚ(Ø¡ô÷ì×í­)
  • stringent factor
    ¾ö°Ý ÀÎÀÚ (åñÌ«ì×í­)
  • Stuart factor
    ½ºÆ©¾Æ¸£Æ® ÀÎÀÚ(ì×í­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
PIF   1) Proliferation Inhibitory Factor
  2) Prolactin release Inhibiting Factor...
P-P factor Pellagra Preventive factor
  = Vitamin G
TDF Testicular-Determining Factor
  = HY Factor
TSHRF Thyrotropin(Thyroid) Stimulating Hormone Releasing Factor
  = Thyrotropin Releasing Fa...
AEF allogenic effect factor; amyloid enhancing factor; aorto-enteric fistula
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
CSD Cat Scratch Disease
CD Celiac Disease
CDC Center for Disease Control
CCD Central Core Disease
CDC Centre for Disease Control
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcific mitral disease
    ¼®È¸È­ ½Â¸ðÆÇ¸· Áúȯ
  • caloric disease
    °í¿Â º´
    °í¿Â¿¡ ³ëÃâµÇ¾î ³ªÅ¸³ª´Â Áúȯ.
  • Canavan's disease
    Ä«³ª¹Ý º´
    »ó¿°»öü ¿­¼º À¯ÀüÇÏ´Â ÁúȯÀ¸·Î ¾Æ½ºÆÄ¸£Å侯½Ç¶óÁ¦
  • Castleman disease
    Castleman º´
    °Å´ë ¸²ÇÁÀý Áõ½Ä ¶Ç´Â ¸²ÇÁÀý °ú¿ÀÁ¾ µîÀ¸·Îµµ ºÒ¸®¿ì´Â ÀÌ ÁúȯÀº Çö¹Ì°æ ¼Ò°ß¿¡ µû¶ó À¯¸®Áú Ç÷°üÇü°ú ÇüÁú ¼¼Æ÷Çü µÎ À¯ÇüÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. À¯¸®Áú Ç÷°üÇüÀº ´Ù¾çÇÑ Å©±âÀÇ ¿©Æ÷·Î ±¸¼ºµÇ°í ÁÖÀ§¿¡ ¿ÜÅõÃþ ¸²ÇÁ±¸ÀÇ Áõ½ÄÀ¸·Î µ¿½É¿øÇüÀÇ ¹è¿­ÀÌ °üÂûµÈ´Ù. ¿©Æ÷ Áß½ÉÀº Ç÷°ü Áõ½Ä°ú Ç÷°ü º®ÀÇ À¯¸®Áú º¯È­·Î µÎ²¨¿öÁ® Hassall ¼Òü¿Í À¯»çÇÏ´Ù. ¿©Æ÷ »çÀÌ °£Áú Á¶Á÷¿¡´Â Ç÷°ü Áõ½Ä°ú ÇÔ²² ÇüÁú ¼¼Æ÷, ¸é¿ª¸ð¼¼Æ÷, È£»ê±¸°¡ ħÀ±ÇÑ´Ù. ÀÓ»óÀû Áõ»óÀÌ ¾øÀÌ ÇÑ °³ÀÇ Á¾±«·Î ³ªÅ¸³ª´Â °æ¿ì¿¡ 90% Á¤µµ°¡ ÃÊÀÚ¾ç Ç÷°üÇüÀ̰í Á¾°Ýµ¿¿¡ È£¹ßÇÏ¸ç ±×¹Û¿¡ °æºÎ, ¾×¿ÍºÎ, Àå°£¸· µî¿¡¼­ ³ªÅ¸³­´Ù. Ç÷Áú¼¼Æ÷ÇüÀº ´Ù¹ß¼ºÀ¸·Î ¿­, ºóÇ÷, ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡, ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Áõ°¡ µîÀÇ ÀÓ»ó Áõ»óÀ» µ¿¹ÝÇÑ´Ù. Àü½ÅÀûÀÎ ÇüÁú¼¼Æ÷ÇüÀº ºñÁ¤»óÀûÀÎ °ú¸é¿ª ¹ÝÀÀÀ¸·Î ¿¹Èİ¡ ÁÁÁö ¾ÊÀ¸¸ç ¾Ç¼º ¸²ÇÁÁ¾À̳ª Ka
  • cat-scratch disease
    °í¾çÀÌ-ÇÒÅ¡ º´, ¹¦¼Òº´
    ÀÌ ÁúȯÀº ±Þ¼º °æ°ú¸¦ ÃëÇÏ¸ç °í¾çÀÌ¿Í Á¢ÃËÇÑ ¾ÆÀ̵é°ú ÀþÀºÀÌ¿¡°Ô¼­ °¡Àå ÈçÇÏ°Ô ¹ß»ýÇÑ´Ù. ÁÖ·Î ÇÒÄû°Å³ª ´Ù¸¥ »óó¸¦ ÅëÇØ¼­ ÀüÆÄµÇÁö¸¸, °ú°Å·ÂÀÌ ¾ø´Â °æ¿ìµµ ÀÖ´Ù. °í¾çÀÌ ÇÒÅ¡ º´Àº ±×¶÷ À½¼º °£»ó±ÕÀÎ Bartonella henselae¿¡ ÀÇÇØ¼­ ÀϾ´Ù. ÇÒÄý ´ÙÀ½ ¸çÄ¥ ÈÄ 1/3¿¡¼­ Á¢Á¾ À§Ä¡¿¡ ÀÏÂ÷Àû »óó°¡ ³ªÅ¸³­´Ù. ÀÌ °÷ÀÌ °¨¿°µÈ °÷À̸ç Áß¾Ó¿¡ ¾×Æ÷³ª ³óÆ÷°¡ ÀÖ´Â °¡Çǰ¡ µ¤Èù ±Ë¾çÀ̳ª ±¸ÁøÀ¸·Î ³ªÅ¸³­´Ù. 1-3ÁÖ ÈÄ¿¡ Àü¹ÝÀûÀÎ °¨¿°ÀÇ ¾ç»óÀÌ º¸ÀÌ¸ç ±¹¼ÒÀû Àӯļ±ÀÌ Àӯļ±¿°ÀÇ ±Ù°Å°¡ ¾øÀÌ Ä¿Áø´Ù. À̰ÍÀº ¾ÐÅëÀÌ ÀÖ°í °íÁ¤µÇ¾î ÀÖÀ¸¸ç ¿°ÁõÀÌ µÚµ¤°í ÀÖ´Ù. ȤÀº ´­·¯µµ ¾ÆÇÁÁö ¾ÊÀ¸¸ç °¥¶óÁø ¾ç»óÀ¸·Î ¿°Áõ ¾ç»ó¾øÀÌ º¸ÀÏ ¼öµµ ÀÖ´Ù. ³óÀÌ »ý±â´Â °ÍÀÌ ÈçÇϸç À̰ÍÀº ¹«±Õ¼º ³óÀÇ ¾ç»óÀÌ´Ù. ÁøÇà °úÁ¤ÀÌ ¾ç¼ºÀÏÁö¶óµµ ¾î¶² °æ¿ì¿£ ¿­ÀÌ ³ª¸ç ¸î ÁÖ µ¿¾È ½ÉÇÑ Àü½Å Áõ»óÀ» º¸À̱⵵ ÇÑ´Ù. ¸²ÇÁÀý Á¾´ë ½Ã¿¡´Â ¸²ÇÁÁ¾À̳ª ´Ù¸¥ ¾Ç¼º Á¾¾ç, °áÇÙ, ¸²ÇÁ À°¾ÆÁ¾, ±Þ¼º ¼¼±Õ¼º °¨¿°°ú °¨º°ÇØ¾ß ÇÑ´Ù.
  • celiac disease
    ¼Ò¾Æ ¸¸¼º ¼ÒÈ­Àå¾ÖÁõ, ¼Ò¾Æ Áö¹æº¯Áõ, º¹ºÎ Áúº´
    1. ½Äǰ ±Û·çÅÙ°ú °ü°è°¡ ÀÖÀ¸¸ç ¾Æ¸¶µµ ÀÌ ´Ü¹éÀÇ ±¸¼º ¼ººÐ¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀ¿¡ ÀÇÇÑ °Í °°´Ù. ¼ÒÀå À¶¸ðÀÇ ±¤¹üÀ§ÇÑ ½ÉÇÑ ¼Ò½Ç°ú ÇÔ²² Èí¼ö Ç¥¸éÀûÀÇ ½ÉÇÑ °¨¼Ò¸¦ Ư¡À¸·Î ÇÑ´Ù. º¸Åë ¼Ò¾Æ¿¡¼­ Ãʱ⿡ Áø´ÜÀÌ µÇÁö¸¸ ¼ö³â ´õ ´Ê°Ô ¹ß°ßµÇ±âµµ ÇÏ°í ¿©ÀÚ°¡ ³²ÀÚº¸´Ù ´õ ÈçÈ÷ ¹ß»ýÇϸç À¯Àü¼º¿¡ ÀÇÇÑ °ÍÀ̶ó »ý°¢µÈ´Ù. ¹«±Û·çÅÙ ½ÄÀÌ¿ä¹ýÀ» ÇÔÀ¸·Î¼­ Ä¡·á°¡ µÉ ¼ö ÀÖ´Ù´Â È®½ÇÇÑ ±Ù°Å°¡ ÀÖ´Ù. 2. 1889³â Gee´Â ¿µ¾ç ½ÇÁ¶Áõ, ºÒ·® ¼ÒÈ­º¯, º¹ºÎ ÆØ¸¸À» ÁÖ Áõ»óÀ¸·Î ÇÑ ¸¸¼º ÁúȯÀ» celiac º´À̶ó°í º¸°íÇß´Ù. ÀÓ»ó Áõ»óÀº ¼³»ç, º¹Åë, ±¸Åä µîÀÇ À§Àå Áõ»ó À̿ܿ¡ ºóÇ÷, »ö¼Ò Ä§Âø ÀÌ»ó, ´Ù¹ß¼º ½Å°æ¿°, ¼³¿°, °£, ºñÁ¾, ÀüÇØÁú ÀÌ»óÀ» ³ªÅ¸³½´Ù. È£¹ß ¿¬·ÉÀº À¯¾Æ±â¿Í Àå³â±âÀÌ´Ù. º´¸® ¼Ò°ßÀº ¼ÒÀåÀÇ Á¡¸· À¶¸ðÀÇ ¼öÃà ³»Áö ¼Ò½Ç, Á¡¸· °íÀ¯Ãþ¿¡ÀÇ ¸²ÇÁ±¸¿Í ÇüÁú ¼¼Æ÷ÀÇ Ä§À±À» ÀÎÁ¤ÇÒ ¼ö ÀÖ´Ù.
  • cerebral vascular disease
    ³ú Ç÷°ü Áúȯ
  • cervical degenerative joint disease
    ÅðÇ༺ °æ°üÀý Áúȯ
  • Chagas' disease
    »þ°¡½º º´
    ¾Æ¸Þ¸®Ä« Æ®¸®ÆÄ³ë¼Ò¸¶Áõ try
  • chester's disease
    ü½ºÅÍ º´
    °ñÀýÀÌ µû¸£´Â Ȳ»öÁ¾.
  • Chiari disease
     º´
    °£ Æó¼â¼º Á¤¸Æ ³»¸·¿°.
  • chronic disease
    ¸¸¼º Áúȯ
    º´ÀÇ °æ°úÀÇ Àå´Ü¿¡ ÀÇÇÑ ºÐ·ù. º¸Åë 6°³¿ù ȤÀº l³â ÀÌ»ó °è¼ÓµÇ´Â ÁúȯÀ» ¸»Çϸç, ±Þ¼º Áúȯ°ú ´ëÀÀÇÑ´Ù. ±× Áõ¼¼°¡ ¿Ï¸¸ÇÏ°Ô ³ªÅ¸³ª Àå±â°£ Áö¼ÓÇϹǷΠ¸¸¼º Áõ»óÀ̶ó Çϸç, À̰͵µ ±Þ¼º Áúȯ¿¡¼­ÀÇ ±Þ¼º Áõ»ó¿¡ ´ëÀÀÇÏ´Â ¸»ÀÌ´Ù. ´ëÇ¥ÀûÀÎ ¸¸¼º ÁúÇÑÀ¸·Î´Â °áÇÙ, ³ªº´, ¸Åµ¶ µîÀÌ ÀÖ°í, ±Þ¼º Áúȯ¿¡¼­ ÀÌÇàÇÏ´Â °Íµµ ¸¹´Ù. ´Ü¼øÈ÷ ¾ËÄÚ¿Ã Áßµ¶À̳ª °üÀý ·ù¸ÓƼÁò µîÀÇ °æ¿ì´Â ¸¸¼ºÀ¸·Î º¸´Â °æ¿ì°¡ ¸¹´Ù.
  • coeliac disease
    º¹°­ Áúȯ
  • cold hemagglutinin disease
    ÇÑ·© Ç÷ÀÀÁý¼Òº´
  • collagen disease
    ±³¿ø Áúȯ, ±³¿øÁú Áúȯ, ±³¿øº´, ±³¿øÁúº´
    µ¿ÀǾî=connective tissue disorders. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î Ç÷°üÀÇ °áÇÕ Á¶Á÷¿¡ ÆØÈ­³ª ±«»ç µûÀ§ÀÇ º¯È­°¡ ¹ß°ßµÇ´Â ¸ðµç ÁúȯÀ» ÀϰýÇÏ¿©, ±×µéÀÇ »óÈ£°ü·ÃÀ» º¸±â À§ÇØ 1942³â ¹Ì±¹ÀÇ O. Ŭ·½Æä·¯ µî¿¡ ÀÇÇØ¼­ Á¦ÃâµÈ Áý¾à °³³ä.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
decay accelerating factor <biochemistry, protein> Plasma protein that regulates complement cascade by blocking the formation of the C3bBb complex (the C3 convertase of the alternate pathway).
Widely distributed in tissues but deficient in paroxysmal nocturnal haemoglobinuria.
(18 Nov 1997)
suppressor factor <immunology> Factors released by T suppressor cells.
See: suppressor mutation, ochre suppressor, opal suppressor.
(19 Jan 1998)
diabetogenic factor Rarely used term for a factor in crude extracts of the anterior lobe of the hypophysis that produces degenerative changes in the islet cells of the pancreas and causes permanent diabetes.
(05 Mar 2000)
diffusing factor <enzyme> Enzyme that degrades hyaluronic acid, found in lysosomes.
(18 Nov 1997)
direct lytic factor of cobra venom A polypeptide of 62 residues; action on cells is similar to that of melittin in that it promotes disruption of membranes; used as an investigational antirheumatic agent.
Synonym: cobra toxin, direct lytic factor of cobra venom.
(05 Mar 2000)
Duran-Reynals permeability factor <enzyme> Enzyme that degrades hyaluronic acid, found in lysosomes.
(18 Nov 1997)
duty factor <radiobiology> Ratio of the duration of time when a system is actually operating to the total time for a complete cycle of the system. For example: if a tokamak experiment runs for 5 seconds and then sits for 500 seconds while the power supplies are recharged, then the duty factor is 1%. Similar to capacity factor for powerplants.
Synonym: duty cycle.
(09 Oct 1997)
q-factor <radiobiology> Ratio of power produced by fusion to power put into the reactor to heat the plasma and drive the magnetic fields.
Q = 1 is the definition of scientific breakeven, where power out = power in. Economical fusion will require Q significantly greater than 1. Fortunately Q increases dramatically as the plasma parameters approach the Lawson criterion for ignition. Power to drive the magnetic fields is frequently ignored in discussions of Q, with the justification that a steady-state, continuous-output fusion reactor will have superconducting magnet coils.
(15 Dec 1997)
quality factor <radiobiology> (Q) A multiplying factor used with absorbed dose to convert to dose equivalent and therefore to express the radiation's effectiveness in causing biological effects.
(16 Dec 1997)
inhibition factor <growth factor> A soluble, nondialysable factor that is produced by sensitised lymphocytes following exposure to a specific antigen. It inhibits macrophage migration and causes adherence.
It was originally defined on the basis of inhibition of emigration of mononuclear cells from capillary (haematocrit) tubes, more recently a 13 kD protein with migration inhibitory activity has been isolated.
Acronym: MIF
Synonym: inhibition factor.
(22 Sep 2002)
initiation factor One of several soluble proteins involved in the initiation of protein or RNA synthesis.
(05 Mar 2000)
insulin activating factor <chemical> Activates insulin gene transcription in pancreatic beta cells.
Synonym: insaf
(05 Dec 1998)
insulin-antagonizing factor A principle in extracts of the anterior lobe of the hypophysis that raises the blood sugar and antagonises the action of insulin; purified pituitary growth hormone produces an identical effect.
Synonym: insulin-antagonizing factor.
(05 Mar 2000)
insulin like growth factor <growth factor> Insulin like growth factors I and II are polypeptides with considerable sequence similarity to insulin.
They are capable of eliciting the same biological responses, including mitogenesis in cell culture. On the cell surface, there are two types of insulin like growth factor receptor, one of which closely resembles the insulin receptor (which is also present).
Insulin like growth factor I = somatomedin A = somatomedin C
Insulin like growth factor II = MSA (Multiplication stimulating activity).
Insulin like growth factor 1 is released from the liver in response to growth hormone.
Acronym: IGF
(18 Nov 1997)
insulin-like growth-factor binding protein 1 One of the six homologous proteins that specifically bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits igf binding to cell surface receptors and thereby inhibits igf-mediated mitogenic and cell metabolic actions. (proc soc exp biol med 1993;204(1):4-29)
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á